CAS: 2305154-31-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine REF: AN-AG01KK6JCAS: 2305154-31-6 | 97% | 164.00 €~333.00 € | Tue 21 May 24 |
 | JCN037 REF: TM-T8431CAS: 2305154-31-6 | 100% | 52.00 €~762.00 € | Tue 28 May 24 |
 | JCN037 REF: 3D-FSD15431CAS: 2305154-31-6 | Min. 95% | To inquire | Mon 01 Jul 24 |
![N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine](https://static.cymitquimica.com/products/AN/thumb/AG01KK6J.jpg)
N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine
CAS:2305154-31-6
Formula:
C16H11BrFN3O2
Purity:
97%
Molecular weight:
376.1798
Ref: AN-AG01KK6J
| 25mg | 164.00 € | |
| 50mg | 197.00 € | |
| 100mg | 333.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
JCN037
CAS:2305154-31-6
JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of …
Formula:
C16H11BrFN3O2
Purity:
100%
Color and Shape:
Solid
Molecular weight:
376.18
Ref: TM-T8431
| 1mg | 52.00 € | |
| 5mg | 142.00 € | |
| 10mg | 212.00 € | |
| 25mg | 355.00 € | |
| 50mg | 527.00 € | |
| 100mg | 762.00 € | |
| 1ml*10 (DMSO) | 157.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
JCN037
CAS:2305154-31-6
JCN037 is a potent, selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor in clinical …
Formula:
C16H11BrFN3O2
Purity:
Min. 95%
Molecular weight:
376.18 g/mol
Ref: 3D-FSD15431
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
